Publikationen

2012   2011   2010   2009   2008   2007   2006   2005   2004   2003   2002   2001   2000

2012

Originalarbeiten

1. Conner KR, Beautrais AL, Brent DA, Conwell Y, Phillips MR, Schneider B. The next generation of psychological autopsy studies: Part 2. Interview procedures. Suicide Life-Threat. 2012; 42(1):86-103. Epub 2012 Jan 30.

2. Czech C, Berndt P, Busch K, Schmitz O, Wiemer J, Most V, Hampel H, Kastler J, Senn H. Metabolite profiling of Alzheimer’s disease cerebrospinal fluid. PLoS One. 2012. 7(2):e31501. Epub 2012 Feb 16.

3. Gerrish A, Russo G, Richards A, Moskvina V, Ivanov D, Harold D, Sims R, Abraham R, Hollingworth P, Chapman J, Hamshere M, Pahwa JS, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Johnston JA, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Kölsch H, Heun R, Schürmann B, Bussche HV, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Hüll M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Davies G, Harris SE, Starr JM, Deary IJ, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Jones L, Holmans PA, O’Donovan MC, Owen MJ, Williams J. The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer’s disease. J Alzheimers Dis. 2012; 28(2):377-87. Epub 2011 Oct 25.

4. Jacobs HI, Visser PJ, Van Boxtel MP, Frisoni GB, Tsolaki M, Papapostolou P, Nobili F, Wahlund LO, Minthon L, Frölich L, Hampel H, Soininen H, van de Pol L, Scheltens P, Tan FE, Jolles J, Verhey FR. The association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent. Neurobiol Aging. 2012; 33(1):201.e1-8. Epub 2010 Aug 23.

5. Karakaya T, Fußer F, Prvulovic D, Hampel H. Treatment options for tauopathies. Curr Treat Option Ne. 2012; 14(2):126-36. Epub 2012 Feb 4.

6. Knöchel C, Oertel-Knöchel V, O’Dwyer L, Prvulovic D, Alves G, Kollmann B, Hampel H. Cognitive and behavioural effects of physical exercise in psychiatric patients. Prog Neurobiol. 2012; 96(1):46-68. Epub 2011 Nov 24.

7. Knöchel C, Oertel-Knöchel V, Schönmeyer R, Rotarska-Jagiela A, van de Ven V, Prvulovic D, Haenschel C, Uhlhaas P, Pantel J, Hampel H, Linden DE. Interhemispheric hypoconnectivity in schizophrenia: fiber integrity and volume differences of the corpus callosum in patients and unaffected relatives. Neuroimage. 2012; 59(2):926-34. Epub 2011 Sep 26.

8. Koch W, Teipel S, Mueller S, Benninghoff J, Wagner M, Bokde ALW, Hampel H, Coates U, Reiser M, Meindl T. Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer’s disease. Neurobiol Aging. 2012; 33(3):466-78. Epub 2010 Jun 10.

9. Mattsson N, Rosén E, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek MM, Olde Rikkert M, Tsolaki M, Mulugeta E, Aarsland D, Visser PJ, Schroeder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Wallin A, Eriksdotter-Jönhagen M, Minthon L, Winblad B, Blennow K, Zetterberg H. Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology. 2012; 78(7):468-76. Epub 2012 Feb 1.

10. O’Dwyer L, Lamberton F, Bokde AL, Ewers M, Faluyi YO. Tanner C, Mazoyer B, O’Neill D, Bartley M, Collins DR, Coughlan T, Prvulovic D, Hampel H. Using support vector machines with multiple indices of diffusion for automated classification of mild cognitive impairment. PloS One. 2012; 7(2):e32441. Epub 2012 Feb 23.

11. Oertel-Knöchel V, Knöchel C, Rotarska-Jagiela A, Reinke B, Prvulovic D, Haenschel C, Hampel H, Linden DEJ. Association between psychotic symptoms and cortical thickness reduction across the schizophrenia spectrum. Cereb Cortex. 2012 Jan 30. [Epub ahead of print]

12. Oertel-Knöchel V, Reinke B, Hornung A, Knöchel C, Matura S, Knopf M, Prvulovic D, O’Dwyer L, Lindner M, Rau A, Hampel H, Haenschel C, Linden DE. Patterns of autobiographical memory in bipolar disorder examined by psychometric and functional neuroimaging methods. J Nerv Ment Dis. 2012; 200(4):296-304.

13. Roggendorf J, Chen S, Baudrexel S, van de Loo S, Seifried C, Hilker R. Arm swing asymmetry in Parkinson’s disease measured with ultrasound based motion analysis during treadmill gait. Gait Posture. 2012; 35(1):116-20. Epub 2011 Sep 29.

14. Santos AN, Ewers M, Minthon L, Simm A, Silber RE, Blennow K, Prvulovic D, Hansson O, Hampel H. Amyloid-β oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer’s Disease. J Alzheimers Dis. 2012; 29(1):171-6. Epub 2012 Jan 3.

15. Vos S, van Rossum I, Burns L, Knol D, Scheltens P, Soininen H, Wahlund LO, Hampel H, Tsolaki M, Minthon L, Handels R, L’Italien G, van der Flier W, Aalten P, Teunissen C, Barkhof F, Blennow K, Wolz R, Rueckert D, Verhey F, Visser PJ. Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI. Neurobiol Aging. 2012 Jan 19. [Epub ahead of print]

16. Wagner M, Wolf S, Reischies FM, Daerr M, Wolfsgruber S, Jessen F, Popp J, Maier W, Hüll M, Frölich L, Hampel H, Perneczky R, Peters O, Jahn H, Luckhaus C, Gertz HJ, Schröder J, Pantel J, Lewczuk P, Kornhuber J, Wiltfang J. Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. Neurology. 2012; 78(6):379-86. Epub 2012 Jan 11.

17. Wei X, Roettger Y, Tan B, He Y, Dodel R, Hampel H, Wei G, Haney J, Gu H, Johnstone BH, Farlow MR, Du Y. Human anti-prion antibodies block prion peptide fibril formation and neurotoxicity. J Biol Chem. 2012 Feb 23.

18. Yakushev I, Müller MJ, Buchholz HG, Lang U, Rossmann H, Hampel H, Schreckenberger M, Fellgiebel A. Stage-dependent agreement between cerebrospinal fluid proteins and FDG-PET findings in Alzheimer’s disease. Curr Alzheimer Res. 2012; 9(2):241-7. Epub 2011 Oct 26.

Reviews

1. Gerlach M, Maetzler W, Broich K, Hampel H, Rems L, Reum T, Riederer P, Stöffler A, Streffer J, Berg D. Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics. J Neural Transm. 2012; 119(1):39-52. Epub 2011 Jul 14.

Bücher

1. Freitag CM, Barocka A, Fehr C, Grube M, Hampel H (Hg.). Depressive Störungen über die Lebensspanne. Ätiologie, Diagnostik und Therapie. Kohlhammer, Stuttgart, 2012. (im Druck)

2. Hampel H, Carrillo MC (Hg.). Alzheimer’s Disease – Modernizing Concept, Biological Diagnosis and Therapy. Advances in Biological Psychiatry, Vol. 28. Karger Verlag, Basel, 2012. (im Druck)

Buchbeiträge

1. Hampel H, Prvulovic D. Leuchtturm-Projekte in der Demenzforschung. In: Personalakquise im Krankenhaus. Ärzte gewinnen, binden, entwickeln (Hg.: Kirchner H, Schroeter M, Flesch M). Springer, Berlin, Heidelberg, 2012, 106-11. (im Druck)

2. Schneider B, Weber B, Hampel H. Depression im Alter. In: Depressive Störungen über die Lebensspanne (Hg.: Freitag CM, Barocka A, Fehr C, Grube M, Hampel H), Kohlhammer, Stuttgart, 2012. (im Druck)

geändert am 23. April 2012  E-Mail: Dr. med Stefan Hornungpsychiatrie@kgu.de